Biotechnology is poised to enable entirely new manufacturing in the 21st century. The rapid advances in synthetic biology and genome-scale biology are powering new capabilities to make a range of products from basic chemicals to uniquely biologically-enabled products like tissues. Combining these 'front-end' technologies with emerging 'back-end' elements like continuous and integrated operations, automation, and AI/ML can enable new models for accessible biomanufacturing capacity. Growing new capabilities for biomanufacturing could transform the industrial base to enable circular bioeconomies that are both sustainable and prosperous.
Principal Investigator Roman Lubynsky